Remove Assay Development Remove DNA Remove Research Remove White Paper
article thumbnail

Listicle: Maximising outsourcing models beyond time and cost

Drug Discovery World

For these reasons and others, many biotech and pharmaceutical companies – along with government research labs and academic institutions – rely on contract research organizations (CROs) for drug discovery services. Designing DEL libraries has benefited from the development of AI to model compounds based on binding pockets.

article thumbnail

Article FDA Thank You The next chapter in the ctDNA story: Still promising, not ready for prime time

Agency IQ

The next chapter in the ctDNA story: Still promising, not ready for prime time A recent workshop summed up the state of play for circulating tumor DNA. In 2019, the advocacy organization, Friends of Cancer Research (FOCR) organized a multi-stakeholder initiative comprised of industry, government, and academia to find out.

FDA 40